CK20 Rabbit Polyclonal Antibody orb10405 from Biorbyt | Biocompare.com

Supplier Images

CK20 Rabbit Polyclonal Antibody
Cytokeratin 20 antibody

Paraffin-embedded mouse stomach tissue fixed with 4% paraformaldehyde. Antigen retrieval by boiling with citrate buffer. Blocking buffer is goat serum (37 degrees for 20 min.). Cytokeratin 20 antibody at 1:200 dilution with overnight incubation at 4 degre

Be the first to write a review!

Citations:

Supplier Page from
Biorbyt for
CK20 Rabbit Polyclonal Antibody

The CK20 Rabbit Polyclonal Antibody from Biorbyt is a Rabbit Polyclonal antibody to Keratin 20, and KRT20. This antibody recognizes Mouse antigen. The CK20 Rabbit Polyclonal Antibody has been shown to work in the following applications: Western Blot.

Description

CK20 Rabbit Polyclonal Antibody

Product Specs
ItemCK20 Rabbit Polyclonal Antibody
CompanyBiorbyt
Price $250.00Supplier Page
Catalog Numberorb10405
TargetKRT20
Conjugate/TagUnconjugated
ApplicationsWB
Quantity50 ul, 100 ul, 200 ul
ReactivityMouse
ClonalityPolyclonal
FormatLiquid
ImmunogenKLH conjugated synthetic peptide derived from human CK20 (151-250/424aa)
Molecular Weight48 kDa
IsotypeIgG
HostRabbit
Concentration1mg/ml
NCBI Full Gene Namekeratin 20
NCBI Gene AliasesCD20, CK-20, CK20, K20, KRT21
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Research AreaCancer Research, Signal Transduction, Tumor Biomarkers

Specifications/Features

Application Dilutions: WB=1:500-2000

Add to Compare List

Biorbyt

Local Office

Biorbyt

68 TW Alexander Drive

Durham, North Carolina 27713

United States

Phone: +1 (415) 906-5211

Company Profile

International Office

Biorbyt

7, Signet Court, Swann Road

Cambridge, Cambridgeshire CB5 8LA

United Kingdom

Phone: +44(0)1223 815 212
+44(0)1223 280 240 (fax)
+44(0)1223 280 240

Email: info@biorbyt.com
support@biorbyt.com
accounts@biorbyt.com

Company Profile

Website: https://www.biorbyt.com/

(1) Establishment of a direct 2.5D organoid culture model using companion animal cancer tissuesBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieOctober 1, 2022Abugomaa A, Elbadawy M, Yamamoto H, Ayame H, Ishihara Y, Sato Y, Yamawaki H, Kaneda M, Usui T, Sasaki K.

(2) Establishment of 2.5D organoid culture model using 3D bladder cancer organoid cultureScientific reportsJune 10, 2020Abugomaa A, Elbadawy M, Yamanaka M, Goto Y, Hayashi K, Mori T, Uchide T, Azakami D, Fukushima R, Yoshida T, et al.

(3) Family caregiver costs of chronically ill and handicapped children: method and literature reviewPublic Health RepMarch 1, 1989Jacobs P, McDermott S.

(4) [Comparative study of effects of the tyrosine-copper(II) complex on xenobiotic hydroxylation and lipid peroxidation]Biokhimiia (Moscow, Russia)October 1, 1979Karuzina II, Bachmanova GI, Kuznetsova GP, Izotov MV, Archakov AI.

(5) SKF 525-A inhibition, induction, and 452-nm complex formationDrug metabolism and disposition: the biological fate of chemicalsMay 1, 1976Buening MK, Franklin MR.

(6) Effect of pH on substrate and inhibitor kinetic constants of human liver alanine aminopeptidase. Evidence for two ionizable active center groupsBiochemistryNovember 18, 1975Garner CW, Behal FJ.

(7) [Structure formation in interphase adsorption layers of lysozyme at liquid boundaries]BiofizikaJuly 1, 1975Alekseeva IG, Lapina GP, Tulovskaia ZD, Izmaĭlova VN.

(8) Experimental brain ischemia: protection from irreversible damage with a rapid-acting barbiturate (methohexital)StrokeNovember 1, 1972Yatsu FM, Diamond I, Graziano C, Lindquist P.

(9) Inhibition of rat liver esterases by organophosphorus compoundsNatureJanuary 14, 1967Bulmer D, Fisher AW.

Be the First to Write a Review!